MENU

GLUE Monte Rosa Therapeutics Forecast, Technical & Fundamental Analysis

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins... Show more

GLUE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
GLUE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

GLUE is expected to report earnings to fall 2.36% to -38 cents per share on August 06

Monte Rosa Therapeutics GLUE Stock Earnings Reports
Q2'26
Est.
$-0.38
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.10
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.02
The last earnings report on May 07 showed earnings per share of -38 cents, missing the estimate of -36 cents. With 65.44K shares outstanding, the current market capitalization sits at 2.02B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
134
Web
https://www.monterosatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NBXG16.260.59
+3.77%
Neuberger Next Generation Connectivity Fund Inc.
MBCE40.721.19
+3.00%
Monarch Blue Chips Elite Index ETF
NOVZ46.790.52
+1.12%
TrueShares Structured Outcome Nov ETF
SIO25.780.04
+0.14%
Touchstone Strategic Income ETF
CNQQ25.730.03
+0.11%
Rayliant-ChinaAMC Trnsfrmtv Chn Tech ETF

GLUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with CRNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
N/A
CRNX - GLUE
41%
Loosely correlated
N/A
AXON - GLUE
38%
Loosely correlated
N/A
IMNM - GLUE
38%
Loosely correlated
N/A
RVMD - GLUE
37%
Loosely correlated
N/A
KURA - GLUE
36%
Loosely correlated
N/A
More
Monte Rosa Therapeutics (GLUE) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com